VentureSouth — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Kiyateckiyatec.comin𝕏Dec 2022 · $18M
KIYATEC develops 3D Predict, a tumor-specific testing platform that uses patient-derived tumor cells to predict how individual cancers respond to therapies.
BiotechDigital HealthHealthtechMedical DevicesGreenville, US
Matthew Gevaert(Director)Eric Perreault(Executive Officer, Director)inMelissa Rayner(Executive Officer)inScott Isacksen(Executive Officer)inDavid E Orr(Chief Operating Officer)in
BoardChristopher Brotherton(Director)
Co-investorsAtlanta Technology AngelsSeae Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.